Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
REGN

Regeneron

$408.15

-6.03 (-1.46%)

, DERM

Dermira

$12.46

5.63 (82.43%)

13:17
03/18/19
03/18
13:17
03/18/19
13:17
On The Fly
Dermira rises, Regeneron slips on eczema treatment study results »

Shares of Dermira (DERM)…

REGN

Regeneron

$408.15

-6.03 (-1.46%)

DERM

Dermira

$12.46

5.63 (82.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 13

    May

REGN

Regeneron

$409.48

-4.7 (-1.13%)

, DERM

Dermira

$13.49

6.66 (97.51%)

11:38
03/18/19
03/18
11:38
03/18/19
11:38
Recommendations
Piper pokes holes in Dermira data, says buy Regeneron on selloff »

The selloff in shares of…

REGN

Regeneron

$409.48

-4.7 (-1.13%)

DERM

Dermira

$13.49

6.66 (97.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 13

    May

DERM

Dermira

$6.83

-0.07 (-1.01%)

, REGN

Regeneron

$414.18

6.69 (1.64%)

08:15
03/18/19
03/18
08:15
03/18/19
08:15
Recommendations
Dermira shares may rally to $15 or higher on today's data, says Mizuho »

Shares of Dermira (DERM)…

DERM

Dermira

$6.83

-0.07 (-1.01%)

REGN

Regeneron

$414.18

6.69 (1.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 13

    May

Friday
REGN

Regeneron

$414.57

7.08 (1.74%)

, SNY

Sanofi

$45.07

0.72 (1.62%)

16:03
03/15/19
03/15
16:03
03/15/19
16:03
Hot Stocks
Regeneron, Sanofi announce EU approval of new indication for Praluent »

Regeneron (REGN) and…

REGN

Regeneron

$414.57

7.08 (1.74%)

SNY

Sanofi

$45.07

0.72 (1.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Mar

  • 22

    Mar

  • 28

    Apr

  • 13

    May

REGN

Regeneron

$409.80

2.31 (0.57%)

11:54
03/15/19
03/15
11:54
03/15/19
11:54
Conference/Events
Regeneron participates in a conference call with JPMorgan »

JPMorgan Biotech Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 13

    May

Over a week ago
ANAB

AnaptysBio

$71.18

5.26 (7.98%)

, REGN

Regeneron

$415.32

3.22 (0.78%)

11:50
03/12/19
03/12
11:50
03/12/19
11:50
Recommendations
AnaptysBio jumps after JPMorgan surveys doctors on asthma data »

Shares of AnaptysBio…

ANAB

AnaptysBio

$71.18

5.26 (7.98%)

REGN

Regeneron

$415.32

3.22 (0.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 13

    May

REGN

Regeneron

$414.99

2.89 (0.70%)

, SNY

Sanofi

$43.57

0.06 (0.14%)

11:39
03/12/19
03/12
11:39
03/12/19
11:39
Hot Stocks
Regeneron, Sanofi announce FDA approval of Dupixent for adolescent dermatitis »

Regeneron Pharmaceuticals…

REGN

Regeneron

$414.99

2.89 (0.70%)

SNY

Sanofi

$43.57

0.06 (0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

  • 28

    Apr

  • 13

    May

REGN

Regeneron

$410.56

8.02 (1.99%)

, SNY

Sanofi

$43.46

0.47 (1.09%)

15:46
03/11/19
03/11
15:46
03/11/19
15:46
Hot Stocks
Regeneron, Sanofi confirm FDA approval of Dupixent »

Regeneron Pharmaceuticals…

REGN

Regeneron

$410.56

8.02 (1.99%)

SNY

Sanofi

$43.46

0.47 (1.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

  • 11

    Mar

  • 22

    Mar

  • 28

    Apr

  • 13

    May

REGN

Regeneron

$409.48

6.94 (1.72%)

15:15
03/11/19
03/11
15:15
03/11/19
15:15
Hot Stocks
FDA grants approval to Regeneron for Dupixent supplement »

A supplement for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

  • 11

    Mar

  • 28

    Apr

  • 13

    May

REGN

Regeneron

$402.54

-7.04 (-1.72%)

, SNY

Sanofi

$42.99

0.01 (0.02%)

08:17
03/11/19
03/11
08:17
03/11/19
08:17
Conference/Events
Breaking Conference/Events news story on Regeneron, Sanofi »

FDA PDUFA Date for…

REGN

Regeneron

$402.54

-7.04 (-1.72%)

SNY

Sanofi

$42.99

0.01 (0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

  • 22

    Mar

  • 28

    Apr

  • 13

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.